Previous Article | Next Article 
Infect Immun, June 1998, p. 2798-2802, Vol. 66, No. 6
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Time Course and Host Responses to Escherichia
coli Urinary Tract Infection in Genetically Distinct Mouse
Strains
Walter J.
Hopkins,1,*
Annette
Gendron-Fitzpatrick,2
Edward
Balish,1 and
David T.
Uehling1
Department of Surgery1
and
Research Animal Resource
Center,2 University of Wisconsin, Madison,
Wisconsin
Received 28 July 1997/Returned for modification 1 September
1997/Accepted 23 March 1998
 |
ABSTRACT |
Recurrent urinary tract infections (UTIs) are a significant
clinical problem for many women; however, host susceptibility factors
have not been completely defined. The mouse model of induced UTI
provides an experimental environment in which to identify specific host
characteristics that are important in initial bacterial colonization of
the urinary tract and in resolution of an infection. This study
examined initial susceptibility, bacterial clearance, and host defense
mechanisms during induction and resolution of Escherichia
coli UTIs in genetically distinct strains of mice. Of the ten
inbred strains tested, six (BALB/c, C3H/HeN, C57BL/6, DBA.1, DBA.2, and
AKR) showed progressive resolution of bladder infections over a 14-day
period. A constant, low-level bladder infection was observed in SWR
and SJL mice. High bladder infection levels persisted over the
14-day study period in C3H/HeJ and C3H/OuJ mice. Kidney infection
levels generally correlated with bladder infection levels,
especially in C3H/HeJ and C3H/OuJ mice, the two most susceptible
strains, in which infections became more severe with time after
challenge. The degree of inflammation in bladder and kidneys, as well
as antibody-forming cell responses, positively correlated with
infection intensity in all strains except C3H/HeJ, which had minimal
inflammation despite high infection levels. These results demonstrate
two important aspects of host defense against UTI. First, the
innate immune response to an infection in the bladder or kidneys
consists primarily of local inflammation, which is followed by an
adaptive response characterized in part by an antibody response to the
infecting bacteria. Second, a UTI will be spontaneously resolved in
most cases; however, in mice with specific genetic
backgrounds, a UTI can persist for an extended length of time. The
latter result strongly suggests that the presence or absence of
specific host genes will determine how effectively an E. coli UTI will be resolved.
 |
INTRODUCTION |
Urinary tract infections (UTIs) are
one of the most common conditions seen in primary care, hospitals, and
extended-care facilities (17). While UTIs can affect both
men and women, they are far more prevalent in females. Approximately
50% of adult women report having had one or more UTIs, and some of
these women will develop a history of repeated infections (17,
18). A number of studies have sought to define characteristics
that make this patient population unusually susceptible to UTIs. Among
host factors described thus far are increased numbers of receptors for
uropathogenic Escherichia coli on vaginal and bladder
epithelial cells (23), lowered urinary glycosaminoglycan
excretion (19), low levels of cervicovaginal or urinary
antibodies to uropathogens (12, 26, 27), hyporesponsiveness to antigens on uropathogenic E. coli (14),
and specific ABO or Lewis erythrocyte antigen phenotypes (15, 20,
24).
Animal models provide a means to evaluate host factors that affect
resistance to UTIs. Results from studies of mice and rats have revealed
that a genetic component may be important in determining increased UTI
susceptibility. A more severe UTI develops in the SWR and AKR strains
than in BALB/c or C57BL/6 strains when mice are inoculated
intravesically with Enterococcus faecalis (6, 7),
and C3H/OuJ and C3H/HeJ mice are significantly less able to resolve an
E. coli UTI than C3H/HeN mice (10). The
objectives of the current study were to determine the extent to which
the genetic backgrounds of other inbred strains affect induction and resolution of an E. coli UTI and to delineate the
innate and adaptive immune responses elicited by bladder and kidney
infections. Our data on the time course, local inflammatory responses,
and antibody-mediated immunity to a UTI induced in different inbred
mouse strains indicate the capacity of mice to resolve an E. coli UTI and provide further evidence that a genetic component is
associated with host susceptibility and resistance to UTI.
 |
MATERIALS AND METHODS |
Mouse strains.
C3H/HeN mice were purchased from
Harlan-Sprague Dawley (Indianapolis, Ind.). All other strains were
obtained from the Jackson Laboratories (Bar Harbor, Maine). The mouse
strains evaluated in this study do not have major, congenital
immunodeficiencies, although unresponsiveness or hyporesponsiveness to
specific mitogens or antigens has been reported. C3H/HeJ mice are
unresponsive to the B-cell mitogen, lipopolysaccharide (21),
and DBA.1, DBA.2, SJL, and SWR mice are low responders to the T-cell
mitogen phytohemagglutinin (9). Poor responses to protein
antigens such as bacteriophage have been reported for AKR and BALB/c
mice (16), and DBA.1, DBA.2, and SWR strains have diminished
antibody responses to ovomucoid (29). Synthetic antigens
composed of amino acid polymers elicit poor antibody responses in
DBA.1, DBA.2, C57BL/6, and SJL mice (2). Significant
differences between mouse strains have been reported for an immune
response to Salmonella outer membrane proteins. C3H/HeJ and
A/J mice have strong responses, while BALB/c mice respond poorly
(4).
Infection induction and assessment.
Mice were infected by
intravesical inoculation with 108 E. coli
1677 CFU delivered in 50 µl. Virulence characteristics of this strain
include type 1 and P fimbriae, hemolysin, aerobactin, and the O6
serotype. Inoculation procedures and methods for the determination of
bladder and kidney infection levels have been described previously (11, 13). Infection levels at 1, 3, 7, and 14 days after
inoculation were defined as the numbers of viable E. coli cells per milligram of bladder or kidney tissue. The 14-day
study period was based on previous experience with our mouse model,
which indicated that an induced UTI will resolve within this length of
time.
Histopathology.
When the bladder and both kidneys of each
animal were removed for infection assessment, one-half of each organ
was reserved for histopathology evaluation. Sections 5 µm thick were
cut from paraffin-embedded tissue and stained with hematoxylin and
eosin. The degree of inflammation over the total area of each section (both bladder and kidney) was graded by the same veterinary pathologist (A.G.-F.) by the criteria in Table 1.
Slides with sections from untreated animals were identified and used to
establish a baseline for uninfected tissue. Bladder and kidney sections
from infected animals were read without knowledge of bacterial
infection level or time point.
AFC assay.
The antibody-mediated immune response to
infection was evaluated by quantifying the number of splenic
antibody-forming cells (AFCs) produced in response to E. coli 1677 by an enzyme-linked immunosorbent spot assay previously
described (21). In brief, killed E. coli
cells were used to coat plastic petri dishes and then were overlaid
with a suspension of spleen cells. Localized deposition of
anti-E. coli antibody was detected by incubating the
plates with alkaline phosphatase-conjugated anti-immunoglobulin M
(anti-IgM), followed by the addition of substrate and chromogen.
Statistical analyses.
Individual data sets were analyzed by
the most appropriate method, and each statistical test is identified
when a P value is cited. Analyses used were the
Ward's and centroid cluster methods, analysis of variance (ANOVA),
analysis of covariance (ANCOVA), linear regression, Spearman's
rank correlation, and ordinal logistic regression (OLR)
(14).
 |
RESULTS |
Bladder infections.
Figure 1
presents the time course of induced E. coli bladder
infections in 10 different inbred strains of mice. Data on infection levels in C3H strains were previously reported (5) and are included here to provide a comprehensive view of UTI resolution for all
of the strains tested. Cluster analyses were performed to determine
which strains had similar or different patterns of infection
resolution. The results in Fig. 1 indicate three basic patterns of
infection outcomes: (i) progressively resolving from an initial high
infection level, (ii) a constant low infection level, and (iii) not
resolving from an initial high level of infection.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Time course of E. coli bladder
infections in inbred mouse strains. Mice were inoculated intravesically
with 108 E. coli CFU on day 0 and
sacrificed at day 1, 3, 7, or 14. Each point represents the mean number
of E. coli CFU in bladders from 5 or 6 mice. , AKR;
, BALB/c; , C3H/HeJ; , C3H/HeN; , C3H/OuJ; , C57BL/6;
, DBA.1; , DBA.2; ×, SJL; +, SWR.
|
|
Six mouse strains (BALB/c, C3H/HeN, DBA.1, DBA.2,
C57BL/6, and AKR) showed progressive resolution of the induced UTI.
Mice
from these strains had equivalent numbers of bladder CFU on day
1 (
P = 0.44 by ANOVA). Infection levels steadily
decreased over
the next 2 weeks in an approximately linear fashion on a
log-log
scale (slopes ranged from

0.48 to

0.93;
P < 0.001 in all cases;
R2 ranged from 0.54 to
0.81 by linear regression).
Infection levels on day 1 in C3H/OuJ and C3H/HeJ mice were equivalent
to those in mice of the six strains that resolved their
infections
(
P = 0.60 by ANOVA). The C3H/OuJ mice, however, had
UTIs that persisted and became more severe over the 14-day study
period
(slope = 0.41,
P = 0.04, and
R2 = 0.19 by linear regression). Following
a decrease in infection
level on day 3, C3H/HeJ mice had
increasing levels over the remainder
of the study (slope = 0.20,
P = 0.40, and
R2 = 0.04 by
linear regression).
A continual, low-level infection was observed in SWR and SJL mice.
Initial bladder infection levels in these animals were
1% of those
seen in the other eight strains. Numbers of
E. coli CFU
in the bladder did not appreciably change for either strain
over the
14-day study period.
Kidney infections.
Figure 2
presents data on kidney E. coli CFUs in the 10 mouse
strains for which bladder infection levels were also determined. Infection levels for all strains except C3H/HeJ were equivalent 1 day
after inoculation (P > 0.05 by ANOVA). On day 3, C3H/OuJ and DBA.2 mice had higher levels of infection, with bacterial numbers in C3H/OuJ mice increasing to those in C3H/HeJ mice. The remaining strains (AKR, BALB/c, DBA.1, C3H/HeN, C57BL/6, SJL, and SWR)
had either unchanged or lower numbers of kidney E. coli CFU at this time point. At 1 week after inoculation, mice of the last
seven strains and DBA.2 mice had equivalent, minimal kidney infections
that remained unchanged at day 14. In contrast, C3H/HeJ and C3H/OuJ
mice had significantly higher infection levels at both of these later
time points. Data for the C3H strains were previously reported
(5) and are included for comparative purposes.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Time course of E. coli kidney infections
in inbred mouse strains. Mice were inoculated intravesically with
108 E. coli CFU on day 0 and sacrificed at
day 1, 3, 7, or 14. Each point represents the mean number of
E. coli CFU in kidneys from 5 or 6 mice. Symbols are as
defined for Fig. 1.
|
|
We further analyzed these data to determine whether the intensity of
the kidney infection in an individual animal was related
to the level
of bladder infection. Kidney and bladder CFU for
individual mice were
analyzed by Spearman's rank correlation test.
The resulting
correlation coefficient was found to be 0.419 (
P = 0.0001), indicating a moderately high degree of association.
Bladder inflammatory responses.
Mouse strains in which bladder
infections decreased over time (AKR, BALB/c, C3H/HeN, C57BL/6, DBA.1,
and DBA.2) generally had moderate initial inflammatory responses (grade
1 to 2), all of which appeared to decrease with time after
inoculation and decreasing numbers of E. coli CFU (Fig.
3). OLR indicated that the declines
in inflammation were significant for C3H/HeN, C57BL/6, and DBA.1
mice (P < 0.05) and were nearly so for DBA.2 mice
(P = 0.091). In contrast, C3H/HeJ mice had minimal
inflammation throughout the 14-day study with no evidence of change
over 14 days (P = 0.17 by OLR) even though the
intensity of their bladder infections remained high during this period.
The C3H/OuJ mice had an unchanging grade 2 to 3 inflammation throughout
the course of infection (P = 0.59 by OLR). Bladder and
kidney inflammatory responses were previously reported (5)
and are included here for comparison.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
Bladder inflammation scores for inbred mouse strains
during the course of E. coli UTIs. Mice were inoculated
intravesically with 108 E. coli CFU on day
0 and sacrificed at day 1, 3, 7, or 14. The degree of inflammation over
the total area of each section was graded according to the criteria in
Table 1. Each point represents the mean inflammation score of 5 or 6 mice. Symbols are as defined for Fig. 1.
|
|
Kidney inflammation.
Kidney inflammation 1 day after
inoculation was in the range of 0 to slightly greater than 1 for all
mouse strains except C3H/HeN, which had a mean score of 1.7 (Fig.
4). Scores for all strains except C3H/OuJ
were approximately 1 or less for the duration of the 14-day study
period. Mean kidney inflammation scores for C3H/OuJ mice steadily
increased to a maximum of 2.7 on day 14.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 4.
Kidney inflammation scores for inbred mouse strains
during the course of E. coli UTIs. Mice were inoculated
intravesically with 108 E. coli CFU on day
0 and sacrificed at day 1, 3, 7, or 14. The degree of inflammation over
the total area of each section was graded according to the criteria in
Table 1. Each point represents the mean inflammation score of 5 or 6 mice. Symbols are as defined for Fig. 1.
|
|
Splenic AFC responses.
The numbers of IgM anti-E.
coli AFCs/spleen at 1, 3, 7, and 14 days after inoculation for
mice from 10 mouse strains with E. coli UTIs are
presented in Fig. 5. All C3H strain mice
had 4- to 10-fold more anti-E. coli AFCs prior to
infection than mice of the other seven strains (P = 0.0005 by ANOVA). During the first 3 days of the induced UTI,
anti-E. coli AFCs increased in mice of all strains
except DBA.1; thereafter, IgM AFC responses tended to decline or remain
unchanged for the remainder of the 14-day study.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 5.
Anti-E. coli splenic AFC responses in
inbred mouse strains during the course of E. coli UTIs.
Mice were inoculated intravesically with 108 E. coli CFU on day 0 and sacrificed at day 1, 3, 7, or 14. AFCs in
the spleen were detected by an enzyme-linked immunosorbent spot assay
using whole E. coli cells as the target antigens. Each
point represents the mean inflammation score of 5 or 6 mice. Symbols
are as defined for Fig. 1.
|
|
Correlations between infection course and host resistance.
Since infections of the bladder and kidney induce inflammatory and
immune responses, we examined our data for correlations between bladder
and kidney infection levels, inflammation scores, and
anti-E. coli AFCs. Results of analyses using
Spearman's rank correlation coefficient and associated significance
tests showed a moderate degree of association between bladder infection
and inflammation (rs = 0.377, P = 0.0001) as well as between kidney infection and inflammation
(rs = 0.446, P = 0.0001).
Excluded from these analyses were C3H/HeJ mice since they did not
show inflammatory responses despite high infection levels. Splenic AFC
numbers were positively correlated with bladder and kidney infection
levels (rs = 0.327, P = 0.0001 and rs = 0.424, P = 0.0001, respectively).
 |
DISCUSSION |
Variability in the induction and resolution of UTIs in genetically
different mice inoculated with the same E. coli strain indicates that genetic makeup is an important factor in determining host susceptibility and defense against infection. Significant infections were induced and resolved spontaneously in most strains examined; however, SJL and SWR mice had the least-severe UTIs, and
C3H/HeJ and C3H/OuJ mice had intense infections that persisted throughout the 2-week study period. The specific host characteristics that contribute to differences in the induction and resolution of UTIs
in the strains we have studied here are not known at this time. In SWR
and SJL mice, where uropathogenic E. coli did not cause
severe bladder and kidney infections, host genetic factors may decrease
the capacity of E. coli to adhere to bladder epithelial cells. It is also conceivable that in both these strains, as in nonsusceptible women, there is a low density of cellular receptors for uropathogenic E. coli. Alternatively, bladder mucin
may bind to bacterial cellular receptors and block adherence to the
bladder epithelium.
In mice that progressively resolved bladder and kidney infections, it
appeared that local inflammation and induction of an antibody-mediated
immune response to E. coli were temporally related and
associated with infection resolution. The most intense bladder inflammatory responses tended to occur within the first 1 to 3 days
after inoculation and were followed by a marked increase in splenic
anti-E. coli AFCs. Kidney inflammatory responses
were also observed within the first 3 days after inoculation and
coincided with the appearance of AFCs. It is likely that a combination
of these innate and adaptive responses to infection was responsible for
UTI resolution, as has been reported for a diuresing mouse model of
E. coli UTI (3, 25). Here, an influx of
polymorphonuclear neutrophils into the bladder was followed by the
appearance of mononuclear inflammatory cells within 1 week after
intravesical inoculation. Anti-E. coli antibodies were
subsequently detected on bacteria recovered from the urine. The
phagocytosis of bacteria by mononuclear cells such as macrophages
reduces the number of bacteria in infected organs and is also an
important first step in generating adaptive responses. Bacterial
antigens processed by macrophages activate T lymphocytes which, in
turn, participate in the stimulation of antibody-producing B cells.
With the exception of those in C3H/HeJ mice, the AFC responses
seen in mice of the strains tested were very likely initiated through
the bladder inflammatory response. In C3H/HeJ mice, inflammation in the
kidney may have facilitated the recruitment of antigen-presenting
macrophages.
The C3H strains in which infections persisted in the presence of
significant inflammatory or AFC responses provide an opportunity to
identify apparent deficits in their defense mechanisms against an
induced E. coli UTI. In particular, C3H/OuJ mice had
intense bladder and kidney inflammation as well as the largest numbers of splenic AFCs produced in response to E. coli. This
observation indicates that an inflammatory response alone is not
sufficient to resolve an E. coli UTI and suggests some
deficit in the adaptive response. In this regard, antibodies induced by
the infection may not be specific for antigenic sites on bacterial
virulence factors. The C3H/OuJ mice may be capable of making antibodies to many different E. coli antigens so that AFCs are
detected, but they may be unable to produce antibodies which
specifically inhibit bacterial adherence to epithelial cells. It is
also conceivable that C3H/OuJ mice may have a defect in transporting
antibodies into the urine or in phagocytosing opsonized bacteria. We
observed that C3H/HeJ mice had high infection levels in the presence of large numbers of anti-E. coli AFCs but did not have
intense inflammation in the bladder. This result supports the
concept that lipopolysaccharide responsiveness is important for
initiating cytokine-mediated inflammatory responses to
gram-negative bacteria at mucosal surfaces (1, 8).
Whether C3H/HeJ and C3H/OuJ mice have common deficits in antibody-mediated immunity to E. coli or in other host
defense mechanisms remains to be determined.
The data presented here add to that in previous reports by other
investigators on differences between inbred mouse strains in
susceptibility to chronic pyelonephritis. As noted above (3, 4), SWR, AKR, and C57BL/6 mice develop chronic pyelonephritis lasting up to 12 weeks after intravesical inoculation with enterococci; however, we found that these strains did not develop any significant kidney infections following similar inoculation with E. coli. There has also been a report of chronic pyelonephritis in
BALB/c mice infected with E. coli (5), in
contrast to our finding of minimal kidney infections in this strain by
1 week after inoculation. Mice in that study and ours were inoculated
with equivalent numbers of E. coli CFU, but three
separate inoculations over a 16-week period were needed in that study
to achieve chronic kidney infections. Our studies achieved kidney
infections spanning at least 2 weeks in C3H/OuJ mice following a single
inoculation and also showed that kidney pathology increased with length
of infection time. Taken together, these various studies point
to the important finding that there were marked differences in the
induction and clearance of lower- and upper-tract infections in mice
and that these differences are dependent upon the bacterial strain,
mouse strain, and inoculation methods used.
In conclusion, this study has demonstrated that genetically distinct
inbred mice differ in initial susceptibility to an E. coli UTI and ability to resolve an induced infection. Significant UTIs were induced in the majority of mouse strains evaluated, and mice
in all but two strains (C3H/HeJ and C3H/OuJ) were able to successfully
reduce the number of bacteria in bladder and kidneys over a 2-week
period. We have also demonstrated that an antibody-mediated immune
response is elicited by an E. coli UTI in mice,
consistent with results for nonhuman primates (13). The
observation that C3H/HeJ and C3H/OuJ mice had intense, protracted
infections despite significant anti-E. coli AFC
responses suggests that these animals may have one or more genetically
determined deficits in antibody responses to specific E. coli virulence factors or in other host defense mechanisms. A
clearer delineation of these deficits by using the mouse model of UTI
will increase our understanding of genetic factors that may determine
UTI resistance and susceptibility in humans.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Surgery, 600 Highland Ave., Madison, WI 53792. Phone: (608) 263-0887. Fax: (608) 263-0454. E-mail: hopkins{at}surgery.wisc.edu.
Editor: R. E. McCallum
 |
REFERENCES |
| 1.
|
de Man, P.,
C. van Kooten,
L. Aarden,
I. Engberg,
H. Linder, and C. S. Edén.
1989.
Interleukin-6 induced at mucosal surfaces by gram-negative bacterial infection.
Infect. Immun.
57:3383-3388[Abstract/Free Full Text].
|
| 2.
|
Fuchs, S.,
E. Mozes,
A. Maoz, and M. Sela.
1974.
Thymus independence of a collagen-like synthetic peptide and of collagen, and the need for thymus and bone marrow-cell cooperation in the immune response to gelatin.
J. Exp. Med.
139:148-158[Abstract].
|
| 3.
|
Gillon, G.,
M. Small,
O. Medalia, and M. Aronson.
1984.
Sequential study of bacterial clearance in experimental cystitis.
J. Med. Microbiol.
18:319-326[Abstract/Free Full Text].
|
| 4.
|
Gonzalez, C. R.,
M. V. Mejia,
J. Paniagua,
V. Ortiz-Navarette,
G. Ramirez, and A. Isibasi.
1995.
Immune response to porins isolated from Salmonella typhi in different mouse strains.
Arch. Med. Res.
26:S99-S103.
|
| 5.
|
Gupta, R.,
N. K. Ganguly,
V. Ahuja,
K. Joshi, and S. Sharma.
1995.
An ascending non-obstructive model for chronic pyelonephritis in BALB/c mice.
J. Med. Microbiol.
43:33-36[Abstract/Free Full Text].
|
| 6.
|
Guze, P. A.,
L. M. Karavodin,
B. Bonavida,
G. M. Kalmanson,
K. Ishida,
S. Targan, and L. B. Guze.
1985.
Strain-dependent differences in susceptibility of mice to experimental pyelonephritis.
J. Infect. Dis.
152:416-419[Medline].
|
| 7.
|
Guze, P. A.,
G. M. Kalmanson,
K. Ishida, and L. B. Guze.
1987.
Strain-dependent differences in susceptibility of mice to experimental ascending pyelonephritis.
J. Infect. Dis.
156:513-525.
|
| 8.
|
Hedges, S.,
W. Agace,
M. Svensson,
A. Sjogren,
M. Ceska, and C. Svanborg.
1994.
Uroepithelial cells are part of a mucosal cytokine network.
Infect. Immun.
62:2315-2321[Abstract/Free Full Text].
|
| 9.
|
Heininger, H. J.,
B. A. Taylor,
E. J. Hards, and H. Meyer.
1975.
Heritability of the phytohaemagglutinin responsiveness of lymphocytes and its relationship to leukemogenesis.
Cancer Res.
35:825-831[Abstract/Free Full Text].
|
| 10.
|
Hopkins, W. J.,
A. Gendron-Fitzpatrick,
D. O. McCarthy,
J. E. Haine, and D. T. Uehling.
1996.
Lipopolysaccharide-responder and nonresponder C3H mouse strains are equally susceptible to an induced Escherichia coli urinary tract infection.
Infect. Immun.
64:1369-1372[Abstract].
|
| 11.
|
Hopkins, W. J.,
J. A. Hall,
B. P. Conway, and D. T. Uehling.
1995.
Induction of urinary tract infection by intraurethral inoculation with Escherichia coli: refining the murine model.
J. Infect. Dis.
171:462-465[Medline].
|
| 12.
|
Hopkins, W. J., and D. T. Uehling.
1995.
Resolution time of Escherichia coli cystitis is correlated with levels of preinfection antibody to the infecting Escherichia coli strain.
Urology
45:42-46[Medline].
|
| 13.
|
Hopkins, W. J.,
D. T. Uehling, and E. Balish.
1987.
Local and systemic antibody responses accompany spontaneous resolution of experimental cystitis in cynomolgus monkeys.
Infect. Immun.
55:1951-1956[Abstract/Free Full Text].
|
| 14.
|
Hopkins, W. J.,
Y. Xing,
L. A. Dahmer,
E. Balish, and D. T. Uehling.
1995.
Western blot analysis of anti-Escherichia coli serum immunoglobulins in women susceptible to recurrent urinary tract infections.
J. Infect. Dis.
172:1612-1616[Medline].
|
| 15.
|
Kinane, D. F.,
C. C. Blackwell,
R. P. Brettle,
D. M. Weir,
F. P. Winstanley, and R. A. Elton.
1982.
ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women.
Br. Med. J.
285:7-9.
|
| 16.
|
Kölsch, E.,
E. Diller,
G. Weber, and A. J. S. Davies.
1971.
Genetics of the immune response. I. The immune response to the phage fd in high and low responding inbred strains of mice.
Eur. J. Immunol.
1:201-210[Medline].
|
| 17.
|
Kunin, C. M.
1997.
In
Urinary tract infections: detection, prevention, management.
Williams and Wilkins, Baltimore, Md.
|
| 18.
|
Neu, H. C.
1992.
Urinary tract infections.
Am. J. Med.
92:63S-70S[Medline].
|
| 19.
|
Parsons, C. L.
1986.
Pathogenesis of urinary tract infections: bacterial adherence, bladder defense mechanisms.
Urol. Clin. N. Am.
13:563-568[Medline].
|
| 20.
|
Ratner, J. J.,
V. L. Thomas, and M. Forland.
1986.
Relationships between human blood groups, bacterial pathogens, and urinary tract infections.
Am. J. Med. Sci.
292:87-91[Medline].
|
| 21.
|
Rosenstreich, D. L., and L. M. Glode.
1975.
Differences in cell mitogen responsiveness between closely related strains of mice.
J. Immunol.
115:777-780[Abstract/Free Full Text].
|
| 22.
|
SAS Institute, Inc.
1989.
In
SAS/STAT user's guide, version 6.
SAS Institute, Inc., Cary, N.C.
|
| 23.
|
Schaeffer, A. J.,
J. M. Jones, and J. K. Dunn.
1981.
Association of in vitro Escherichia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary tract infections.
N. Engl. J. Med.
304:1062-1066[Abstract].
|
| 24.
|
Sheinfeld, J.,
A. J. Schaeffer,
C. Cordon-Cardo,
A. Rogatko, and W. R. Fair.
1989.
Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women.
N. Engl. J. Med.
320:773-777[Abstract].
|
| 25.
|
Sivan, Y.,
B. Griffel,
O. Medalia, and M. Aronson.
1982.
Comparative histology of the mouse bladder following initial infection and re-infection with Escherichia coli.
J. Pathol.
138:353-364[Medline].
|
| 26.
|
Stamey, T. A.,
N. Wehner,
G. Mihara, and M. Condy.
1978.
The immunologic basis of recurrent bacteriuria: role of cervicovaginal antibody in enterobacterial colonization of the introital mucosa.
Medicine (Baltimore)
57:47-56[Medline].
|
| 27.
|
Tuttle, J. P., Jr.,
H. Sarvas, and J. Koistinen.
1978.
The role of vaginal immunoglobulin A in girls with recurrent urinary tract infections.
J. Urol.
120:742-744[Medline].
|
| 28.
|
Uehling, D. T.,
L. J. James,
W. J. Hopkins, and E. Balish.
1991.
Immunization against urinary tract infection with a multi-valent vaginal vaccine.
J. Urol.
146:223-226[Medline].
|
| 29.
|
Vaz, N. M.,
J. M. Phillips-Quagliata,
B. B. Levine, and E. M. Vaz.
1971.
H-2 linked genetic control of immune responsiveness to ovalbumin and ovomucoid.
J. Exp. Med.
134:1335-1348[Abstract].
|
Infect Immun, June 1998, p. 2798-2802, Vol. 66, No. 6
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Roelofs, J. J. T. H., Rouschop, K. M. A., Teske, G. J. D., Wagenaar, G. T. M., Claessen, N., Weening, J. J., van der Poll, T., Florquin, S.
(2009). Endogenous tissue-type plasminogen activator is protective during ascending urinary tract infection. Nephrol Dial Transplant
24: 801-808
[Abstract]
[Full Text]
-
Andersen-Nissen, E., Hawn, T. R., Smith, K. D., Nachman, A., Lampano, A. E., Uematsu, S., Akira, S., Aderem, A.
(2007). Cutting Edge: Tlr5-/- Mice Are More Susceptible to Escherichia coli Urinary Tract Infection. J. Immunol.
178: 4717-4720
[Abstract]
[Full Text]
-
Garofalo, C. K., Hooton, T. M., Martin, S. M., Stamm, W. E., Palermo, J. J., Gordon, J. I., Hultgren, S. J.
(2007). Escherichia coli from Urine of Female Patients with Urinary Tract Infections Is Competent for Intracellular Bacterial Community Formation. Infect. Immun.
75: 52-60
[Abstract]
[Full Text]
-
Casaz, P., Garrity-Ryan, L. K., McKenney, D., Jackson, C., Levy, S. B., Tanaka, S. K., Alekshun, M. N.
(2006). MarA, SoxS and Rob function as virulence factors in an Escherichia coli murine model of ascending pyelonephritis. Microbiology
152: 3643-3650
[Abstract]
[Full Text]
-
Rouschop, K. M. A., Sylva, M., Teske, G. J. D., Hoedemaeker, I., Pals, S. T., Weening, J. J., van der Poll, T., Florquin, S.
(2006). Urothelial CD44 Facilitates Escherichia coli Infection of the Murine Urinary Tract. J. Immunol.
177: 7225-7232
[Abstract]
[Full Text]
-
Yohe, H. C., O'Hara, K. A., Hunt, J. A., Kitzmiller, T. J., Wood, S. G., Bement, J. L., Bement, W. J., Szakacs, J. G., Wrighton, S. A., Jacobs, J. M., Kostrubsky, V., Sinclair, P. R., Sinclair, J. F.
(2006). Involvement of Toll-like receptor 4 in acetaminophen hepatotoxicity. Am. J. Physiol. Gastrointest. Liver Physiol.
290: G1269-G1279
[Abstract]
[Full Text]
-
Thumbikat, P., Waltenbaugh, C., Schaeffer, A. J., Klumpp, D. J.
(2006). Antigen-specific responses accelerate bacterial clearance in the bladder.. J. Immunol.
176: 3080-3086
[Abstract]
[Full Text]
-
Schilling, J. D., Martin, S. M., Hung, C. S., Lorenz, R. G., Hultgren, S. J.
(2003). Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichiacoli. Proc. Natl. Acad. Sci. USA
100: 4203-4208
[Abstract]
[Full Text]
-
Schilling, J. D., Martin, S. M., Hunstad, D. A., Patel, K. P., Mulvey, M. A., Justice, S. S., Lorenz, R. G., Hultgren, S. J.
(2003). CD14- and Toll-Like Receptor-Dependent Activation of Bladder Epithelial Cells by Lipopolysaccharide and Type 1 Piliated Escherichia coli. Infect. Immun.
71: 1470-1480
[Abstract]
[Full Text]
-
Poljakovic, M., Persson, K.
(2003). Urinary tract infection in iNOS-deficient mice with focus on bacterial sensitivity to nitric oxide. Am. J. Physiol. Renal Physiol.
284: F22-F31
[Abstract]
[Full Text]
-
Zhou, G., Mo, W.-J., Sebbel, P., Min, G., Neubert, T. A., Glockshuber, R., Wu, X.-R., Sun, T.-T., Kong, X.-P.
(2002). Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. J. Cell Sci.
114: 4095-4103
[Abstract]
[Full Text]
-
Mulvey, M. A., Schilling, J. D., Hultgren, S. J.
(2001). Establishment of a Persistent Escherichia coli Reservoir during the Acute Phase of a Bladder Infection. Infect. Immun.
69: 4572-4579
[Abstract]
[Full Text]
-
Asahara, T., Nomoto, K., Watanuki, M., Yokokura, T.
(2001). Antimicrobial Activity of Intraurethrally Administered Probiotic Lactobacillus casei in a Murine Model of Escherichia coli Urinary Tract Infection. Antimicrob. Agents Chemother.
45: 1751-1760
[Abstract]
[Full Text]
-
Rippere-Lampe, K. E., O'Brien, A. D., Conran, R., Lockman, H. A.
(2001). Mutation of the Gene Encoding Cytotoxic Necrotizing Factor Type 1 (cnf1) Attenuates the Virulence of Uropathogenic Escherichia coli. Infect. Immun.
69: 3954-3964
[Abstract]
[Full Text]
-
Means, T. K., Jones, B. W., Schromm, A. B., Shurtleff, B. A., Smith, J. A., Keane, J., Golenbock, D. T., Vogel, S. N., Fenton, M. J.
(2001). Differential Effects of a Toll-Like Receptor Antagonist on Mycobacterium tuberculosis-Induced Macrophage Responses. J. Immunol.
166: 4074-4082
[Abstract]
[Full Text]
-
Schilling, J. D., Mulvey, M. A., Vincent, C. D., Lorenz, R. G., Hultgren, S. J.
(2001). Bacterial Invasion Augments Epithelial Cytokine Responses to Escherichia coli Through a Lipopolysaccharide-Dependent Mechanism. J. Immunol.
166: 1148-1155
[Abstract]
[Full Text]
-
Mulvey, M. A., Schilling, J. D., Martinez, J. J., Hultgren, S. J.
(2000). From the Cover: Bad bugs and beleaguered bladders: Interplay between uropathogenic Escherichia coli and innate host defenses. Proc. Natl. Acad. Sci. USA
97: 8829-8835
[Abstract]
[Full Text]
-
Johnson;, J. R., Hopkins, W. J.
(1998). Reflux in the Mouse Model of Urinary Tract Infection. Infect. Immun.
66: 6063-6064
[Full Text]